Despite medical innovations, the management of
thalassaemia remains associated with significant
risk factors for women during pregnancy, birth
and the postnatal period. The Royal College of
Obstetricians and Gynaecologists (RCOG) has
published guidelines on the management of
thalassaemia during pregnancy and recommends
that women be considered high-risk and managed
with multidisciplinary health-care involvement
(Ansari et al, 2016).